Medicare patients are fully covered under the following scenarios: Stage II/III colorectal cancer for Signatra testing With solid tumors on immuno-therapy for Signatera testing With stages III and IV solid tumors for Altera testing If Signatera is still requested for other cancer types which fall outside of the Medicare stated coverage, an ABN will be required.